IRIS
NIKOLIC, Dragana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 947
NA - Nord America 464
EU - Europa 273
SA - Sud America 227
AF - Africa 18
AN - Antartide 1
OC - Oceania 1
Totale 1.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 441
SG - Singapore 407
HK - Hong Kong 235
BR - Brasile 193
CN - Cina 151
IT - Italia 96
VN - Vietnam 66
RU - Federazione Russa 53
DE - Germania 33
ID - Indonesia 24
FR - Francia 17
GB - Regno Unito 15
AR - Argentina 12
IN - India 12
NL - Olanda 11
BD - Bangladesh 10
CA - Canada 9
EC - Ecuador 8
MX - Messico 8
ZA - Sudafrica 8
AT - Austria 7
ES - Italia 7
RS - Serbia 6
FI - Finlandia 5
TR - Turchia 5
EG - Egitto 4
IL - Israele 4
IQ - Iraq 4
JP - Giappone 4
LT - Lituania 4
PL - Polonia 4
SA - Arabia Saudita 4
SE - Svezia 4
BE - Belgio 3
CO - Colombia 3
HN - Honduras 3
PY - Paraguay 3
UY - Uruguay 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
TJ - Tagikistan 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
GD - Grenada 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 1.931
Salva come PNG Salva come JPEG
Città #
Hong Kong 234
Singapore 125
Beijing 89
Ashburn 86
Bari 25
Ho Chi Minh City 23
Dallas 22
Los Angeles 21
Chicago 17
Buffalo 16
São Paulo 16
Hanoi 15
Munich 15
Jakarta 13
Milan 13
Santa Clara 13
New York 9
Nuremberg 7
Rio de Janeiro 7
Belgrade 6
Brooklyn 6
Council Bluffs 6
Frankfurt am Main 6
Amsterdam 5
Dhaka 5
London 5
Palermo 5
Toronto 5
Boardman 4
Catania 4
Charlotte 4
Falkenstein 4
Goiânia 4
Johannesburg 4
North Bergen 4
Orem 4
Shanghai 4
Vienna 4
Belo Horizonte 3
Benevento 3
Biên Hòa 3
Brasília 3
Brussels 3
Cairo 3
Caxias do Sul 3
Chennai 3
City of London 3
Denver 3
Florianópolis 3
Haiphong 3
Hortolândia 3
Ninh Bình 3
Pagani 3
Poplar 3
Riyadh 3
Rome 3
Roubaix 3
Tampa 3
Tokyo 3
Turku 3
Zhengzhou 3
Altamura 2
Amman 2
Baghdad 2
Belford Roxo 2
Bologna 2
Boston 2
Brno 2
Buenos Aires 2
Canoas 2
Cape Town 2
Carapicuíba 2
Ceppaloni 2
Cetraro 2
Curitiba 2
Da Nang 2
Diadema 2
Duartina 2
Dushanbe 2
Elk Grove Village 2
Forest City 2
Fortaleza 2
Greenville 2
Guayaquil 2
Helsinki 2
Lancaster 2
Manhuaçu 2
Mexico City 2
Moita Bonita 2
Montevideo 2
Montreal 2
Mumbai 2
Osasco 2
Pandino 2
Paris 2
Phoenix 2
Porto Alegre 2
Praia Grande 2
Ribeirão Preto 2
Romola 2
Totale 1.002
Salva come PNG Salva come JPEG
Nome #
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 90
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 71
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 67
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 62
Alcoholic liver cirrhosis, more than a simple hepatic disease - A brief review of the risk factors associated with alcohol abuse 59
An overview of statin-induced myopathy and perspectives for the future 51
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 44
Drug evaluation: The combination of fenofibrate and simvastatin for the treatment of dyslipidemia: When and for whom? 44
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 43
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 43
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 43
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 43
An evaluation of RVX-208 for the treatment of atherosclerosis 41
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 40
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 40
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 40
Anti-cytokine therapy for prevention of atherosclerosis 39
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study 38
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 37
Can the effects of gender, menopause and ageing on lipid levels be differentiated? 36
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 36
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 35
Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers 32
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 32
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 29
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect 28
Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents 28
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 26
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 26
Preliminary results of CitraVes™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 25
Management of Statin Intolerance in 2018: Still More Questions Than Answers 25
Effects of chitosan on plasma lipids and lipoproteins: A 4-month prospective pilot study 24
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 24
Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives 24
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality 23
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 23
Natural approaches in metabolic syndrome management 22
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 22
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 21
Intensive LDL-cholesterol lowering therapy and neurocognitive function 20
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 18
Uric acid metabolism in pre-hypertension and the metabolic syndrome 17
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 17
The role of fibrate treatment in dyslipidemia: an overview 17
Periodontitis, blood lipids and lipoproteins 16
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 16
Small, dense LDL: an update 16
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 15
The Role of Nutraceuticals in Statin Intolerant Patients 15
Peroxisome proliferator-activated receptors and atherosclerosis 15
Exosomal Heat Shock Proteins as New Players in Tumour Cell-to-Cell Communication 15
Nutraceuticals as new therapeutic strategies for health and wellbeing 15
Psoriasis and acute coronary syndrome risk 14
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 14
The extra-glycemic effects of liraglutide: Focus on cardiometabolic markers 14
Oxidative stress and the role of antioxidative treatment in diabetes mellitus 14
Novel anti-obesity drugs and plasma lipids 14
Serum lipoproteins are not associated with the severity of asthma 14
Subfractions and subpopulations of HDL: An update 14
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 14
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: Current knowledge and future perspective 14
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? 13
Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation 13
Emerging approaches for the treatment of hypertriglyceridemia 12
Nutraceuticals as an important part of combination therapy in dyslipidaemia 12
ETC-1002: A future option for lipid disorders? 12
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: A prospective pilot study 12
Serum low density lipoprotein subclasses in asthma 12
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 12
EXOSOMES: PROMISING NON-INVASIVE DIAGNOSTIC AND THERAPEUTIC TOOLS 12
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches 12
LDL and HDL subfractions, dysfunctional HDL: treatment options 12
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 11
Incretins, pregnancy, and gestational diabetes 11
The effect of bergamot on dyslipidemia 11
Statins and new-onset diabetes 11
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials 11
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 10
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 10
IMPROVE-IT: What have we learned? 10
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 10
Regulation of inducible Nitric Oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure 10
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 9
Incretin-based therapies, glucometabolic health and endovascular inflammation 9
Statin treatment in the elderly: how much do we know? 7
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 1
Totale 2.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202393 0 0 0 0 0 0 0 0 0 0 90 3
2023/2024114 0 0 1 80 0 3 0 2 7 3 5 13
2024/2025802 15 3 38 18 33 43 56 75 44 30 127 320
2025/20261.070 341 134 144 237 203 11 0 0 0 0 0 0
Totale 2.079